Total Funding
79
64
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
27430
Remedium Bio is a gene therapy company focused on the development of highly innovative treatments for a broad range of diseases.
Frank Luppino: President and CEOPast Role: Anika Therapeutics, Chief Operating Officer- Alexey Seregin: Vice President of Research & Development
About the Company
Remedium Bio is a Boston area gene therapy company focused on the development of curative treatments for a number of highly debilitating conditions. Our fundamental approach to product development utilizes proven technologies in novel ways to treat well-characterized disease pathology. To streamline R&D, we modularly apply elements of proven
technology to develop local, targeted treatments focusing on clinically validated molecules and mechanistic pathways. Today, our leading candidates include gene therapy treatments in the fields of Rheumatology / Osteoarthritis, Endocrinology / Diabetes, and Neurology / Stroke.
